Dirk Brockstedt

Dirk Brockstedt

Director/Board Member at HELIX BIOPHARMA CORP.
57 year
Health Technology
Miscellaneous
Consumer Services

Profile

Dirk G.
Brockstedt
is an Independent Director at Helix BioPharma Corp.
starting in 2026.
Dr. Brockstedt is an Executive-in-Residence at ShangPharma Innovation, Inc. Former roles include Chief Scientific Officer at Rapt Therapeutics, Inc. from 2019 to 2026, Executive Vice President-Research & Development at Aduro BioTech, Inc. from 2016 to 2017, Director-Research at Anza Therapeutics, Inc. from 2007 to 2009, Immunology Director at Cerus Corp.
from 2002 to 2007, and Senior Research Scientist at Aventis, Inc. Education includes graduate and doctorate degrees from the University of Kiel.

Dirk Brockstedt active positions

CompaniesPositionStart
HELIX BIOPHARMA CORP. Director/Board Member 27/09/2026
Consultant / Advisor -

Former positions of Dirk Brockstedt

CompaniesPositionEnd
RAPT THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 02/03/2026
CHINOOK THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 30/11/2017
Chief Tech/Sci/R&D Officer 31/12/2008
CERUS CORPORATION Corporate Officer/Principal 31/12/2006
Corporate Officer/Principal -
See the detail of Dirk Brockstedt's experience

Education of Dirk Brockstedt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

59

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Miscellaneous

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

  1. Stock Market
  2. Insiders
  3. Dirk Brockstedt